产品编号 :
Cas No. :
CAS No. |
113274-56-9 |
|---|---|
中文名称 |
HIRUDIN (54-65) (DESULFATED)水蛭素 |
英文名称 |
glycyl-L-aspartyl-L-phenylalanyl-L-glutamyl-L-glutamyl-L-isoleucyl-L-prolyl-L-glutamyl-L-glutamyl-L-tyrosyl-L-leucyl-L-glutamine |
别名 |
HIRUDIN (54-65) (DESULFATED);HIRUDIN FRAGMENT 54-65 NON-SULFATED;H-GLY-ASP-PHE-GLU-GLU-ILE-PRO-GLU-GLU-TYR-LEU-GLN-OH;GLY-ASP-PHE-GLU-GLU-ILE-PRO-GLU-GLU-TYR-LEU-GLN;Hirudin;GDFEEIPEEYLQ;L-Glutamine, glycyl-L-α-aspartyl-L-phenylalanyl-L-α-glutamyl-L-α-glutamyl-L-isoleucyl-L-prolyl-L-α-glutamyl-L-α-glutamyl-L-tyrosyl-L-leucyl-;HIRUDIN (54-65) (DESULFATED) USP/EP/BP |
标准英文名 |
glycyl-L-aspartyl-L-phenylalanyl-L-glutamyl-L-glutamyl-L-isoleucyl-L-prolyl-L-glutamyl-L-glutamyl-L-tyrosyl-L-leucyl-L-glutamine |
MDL No. |
MFCD31807308 |
分子式 |
C66H93N13O25 |
分子量 |
1468.54 |
精确分子量 |
1467.64 |
SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O |
标准SMILES |
CC(C)C[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O |
用途 |
Anticoagulant activity: Hirudin is a highly specific and potent direct thrombin inhibitor, effectively blocking thrombin's proteolytic function without requiring endogenous cofactors, offering advantages over heparin such as lower dosage and reduced risk of hemorrhage; Antithrombotic effects; Improvement of microcirculation and promotion of metabolism; Facilitation of hematoma absorption in acute cerebral hemorrhage, reduction of perifocal inflammatory response and edema, alleviation of elevated intracranial pressure, improvement of local circulation, and support for neurological recovery; also promotes absorption of experimental local hematomas (e.g., in the ear); Reduction of cholesterol and triglyceride levels in experimental hyperlipidemia; Inhibition of tumor cell proliferation, particularly hepatocellular carcinoma; enhancement of infiltration of anticancer drugs and immune-active cells into tumor tissues due to its potent anticoagulant properties; Protection against myocardial ischemia and arrhythmias: aqueous extracts show significant protective effects against acute myocardial ischemia and arrhythmia; intraperitoneal hirudin increases nutritional blood flow; intravenous hirudin reduces atrial fibrillation and perifocal inflammation, with similar effects observed in subcutaneous hematoma models; Management of diabetes and its complications: acts as an insulin sensitizer, enhancing endogenous insulin sensitivity and lowering blood glucose; reduces vascular wall inflammation and prevents thrombosis, thereby mitigating diabetic complications such as retinopathy, nephropathy, and limb necrosis; inhibition of proliferative vitreoretinopathy (PVR) by reducing laminin and type IV collagen levels in the vitreous cavity after ocular trauma; Antitumor and antimetastatic effects: suppresses growth and proliferation of various tumor cells (e.g., A549 non-small cell lung cancer, MDA-MB-231 breast cancer, B16F10 melanoma, 4T1 breast cancer); inhibits tumor implantation and growth in xenograft and syngeneic mouse models; induces tumor nodule necrosis; reduces intravasation of tumor cells and spontaneous lung metastasis; suppresses prostate cancer development and progression in TRAMP mice, as evidenced by decreased tumor volume, incidence, and weight; inhibits proliferation of tumor cells (e.g., MCF-7, A-431, Sk-Mel-28) induced by bronchoalveolar lavage fluid from lung cancer patients; prevents tumor cell dissemination and pulmonary colonization in experimental metastasis models. |
InChIKey |
ZNEKMMIWGPUTGR-SQJOKQRMSA-N |
|
|
评论 |
|---|